Russian journal of anaesthesiology and reanimatology 2, 2019 Клинические рекомендации фар
Авторы заявляют об отсутствии конфликта интересов
жүктеу/скачать 0,76 Mb. Pdf көрінісі
|
| Авторы заявляют об отсутствии конфликта интересов.
The authors declare no conflicts of interest. ЛИТЕРАТУРА/REFERENCES 1. Boral B, Williams D, Boral L. Disseminated Intravascular Coagulation. Am J Clin Pathol . 2016;146(6):670-680. 2. Levi M, van der Poll T. A short contemporary history of disseminated intra- vas cu lar coagulation. Semin Thromb Hemost. 2014;40(8): 874-880. 3. Levi M. Pathogenesis and diagnosis of disseminated intravascular coagulation. Int J Lab Hematol . 2018;40(Suppl 1):15-20. 4. Vaught A. Critical Care for the Obstetrician and Gynecologist: Obstetric Hemorrhage and Disseminated Intravascular Coagulopathy. Obstet Gynecol Clin North Am. 2016;43(4):611-622. 5. Colling M, Bendapudi P. Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis. Transfus Med Rev. 2018;32(2):69-76. 6. Lécuyer H, Borgel D, Nassif X, Coureuil M. Pathogenesis of meningococcal purpura fulminans. Pathog Dis. 2017;75(3). 7. Perera T, Murphy-Lavoie H. Purpura Fulminans. 2018. Stat Pearls [Internet]. Treasure Island (FL): Available at: https://www.ncbi.nlm.nih.gov/books/NBK532865/ 8. National Clinical Guideline Centre (UK). Blood Transfusion. London: Na- ti onal Institute for Health and Care Excellence (UK); 2015. Available at: https://www.ncbi.nlm.nih.gov/books/NBK11822/ 9. O’Brien K, Shainker S, Lockhart E. Transfusion Management of Obstetric Hemorrhage. Transfus Med Rev. 2018;32(4):249-255. Клинические рекомендации ФАР FAR Clinical Recommendations 24 АНЕСТЕЗИОЛОГИЯ И РЕАНИМАТОЛОГИЯ 2, 2019 10. Flint A, McQuilten Z, Wood E. Massive transfusions for critical bleeding: is everything old new again? Transfus Med. 2018;28(2):140-149. 11. Woods T, Scott K, Quick A. New Advances in the Care of the Hemorrhaging Patient. Mo Med. 2018;115(5):434-437. 12. Gatta L, Lockhart E, James A. Blood Products in the Management of Ab- nor mal Placentation. Clin Obstet Gynecol. 2018;61(4):828-840. 13. Jackson D, DeLoughery T. Postpartum Hemorrhage: Management of Mas- sive Transfusion. Obstet Gynecol Surv. 2018;73(7):418-422. 14. Tanaka H, Matsunaga S, Yamashita T, Okutomi T, et al. A systematic review of massive transfusion protocol in obstetrics. Taiwan J Obstet Gynecol. 2017;56(6):715-718. 15. Foster J, Sappenfield J, Smith R, Kiley S. Initiation and Termination of Massive Transfusion Protocols: Current Strategies and Future Prospects. Anesth Analg . 2017;125(6):2045-2055. 16. Pacheco L, Saade G, Costantine M, Clark S, Hankins G. An update on the use of massive transfusion protocols in obstetrics. Am J Obstet Gynecol. 2016;214(3):340-344. 17. Lavee O, Kidson-Gerber G. Update on inherited disorders of haemostasis and pregnancy. Obstet Med. 2016;9(2):64-72. 18. Cohen H, O’Brien P (ed.). Disorders of Thrombosis and Hemostasis in Pregnancy. A Guide to Management. Springer. 2012;252. 19. Marder VJ, et al. Hemostasis and thrombosis: basic principles and clinical practice . 6th ed. Lippincott Williams & Wilkins, 2013;1566. 20. Edwards H. Aetiology and treatment of severe postpartum haemorrhage. Dan Med J. 2018;65(3):B5444. 21. Katz D, Beilin Y. Disorders of coagulation in pregnancy. Br J Anaesth. 2015;115(Suppl 2):75-88. 22. Bannow B, Konkle B. Inherited Bleeding Disorders in the Obstetric Patient. Transfus Med Rev . 2018;32(4):237-243. 23. Nyfløt L, Sandven I, Stray-Pedersen B, Pettersen S, et al. Risk factors for severe postpartum hemorrhage: a case-control study. BMC Pregnancy жүктеу/скачать 0,76 Mb. Достарыңызбен бөлісу:
|